{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:00:26Z","timestamp":1793048426838,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00415-025-12927-2","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T20:05:12Z","timestamp":1739304312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington\u2019s disease"],"prefix":"10.1007","volume":"272","clinical-trial-number":[{"clinical-trial-number":"nct05769972","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Andrea","family":"Moreu-Valls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8883-4947","authenticated-orcid":false,"given":"Arnau","family":"Puig-Davi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Martinez-Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Sampedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Perez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Horta-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Olmedo-Saura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"12927_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2217\/nmt.14.58","volume":"5","author":"SC Andrews","year":"2015","unstructured":"Andrews SC, Dominguez JF, Mercieca EC, Georgiou-Karistianis N, Stout JC (2015) Cognitive interventions to enhance neural compensation in Huntington\u2019s disease. Neurodegener Dis Manag 5:155\u2013164","journal-title":"Neurodegener Dis Manag"},{"key":"12927_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mds.28839","volume":"37","author":"I Aracil-Bolanos","year":"2022","unstructured":"Aracil-Bolanos I, Martinez-Horta S, Gonzalez-de-Echavarri JM, Sampedro F, Perez-Perez J, Horta-Barba A, Campolongo A, Izquierdo C, Gomez-Anson B, Pagonabarraga J, Kulisevsky J (2022) Structure and dynamics of large-scale cognitive networks in Huntington\u2019s disease. Mov Disord 37:343\u2013353","journal-title":"Mov Disord"},{"key":"12927_CR3","first-page":"CD03260","volume":"2013","author":"A Bahar-Fuchs","year":"2013","unstructured":"Bahar-Fuchs A, Clare L, Woods B (2013) Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer\u2019s disease and vascular dementia. Cochrane Database Syst Rev 2013:CD03260","journal-title":"Cochrane Database Syst Rev"},{"key":"12927_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mds.25750","volume":"29","author":"LJ Beglinger","year":"2014","unstructured":"Beglinger LJ, Adams WH, Langbehn D, Fiedorowicz JG, Jorge R, Biglan K, Caviness J, Olson B, Robinson RG, Kieburtz K, Paulsen JS (2014) Results of the citalopram to enhance cognition in Huntington disease trial. Mov Disord 29:401\u2013405","journal-title":"Mov Disord"},{"key":"12927_CR5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/09602011.2011.573255","volume":"21","author":"G Berlucchi","year":"2011","unstructured":"Berlucchi G (2011) Brain plasticity and cognitive neurorehabilitation. Neuropsychol Rehabil 21:560\u2013578","journal-title":"Neuropsychol Rehabil"},{"key":"12927_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.neuropsych.13070169","volume":"27","author":"J Callaghan","year":"2015","unstructured":"Callaghan J, Stopford C, Arran N, Boisse MF, Coleman A, Santos RD, Dumas EM, Hart EP, Justo D, Owen G, Read J, Say MJ, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Bachoud-Levi AC, Bourdet C, van Duijn E, Craufurd D (2015) Reliability and factor structure of the short problem behaviors assessment for Huntington\u2019s disease (PBA-s) in the TRACK-HD and REGISTRY studies. J Neuropsychiatry Clin Neurosci 27:59\u201364","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"12927_CR7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cercor\/bht234","volume":"25","author":"SB Chapman","year":"2015","unstructured":"Chapman SB, Aslan S, Spence JS, Hart JJ Jr, Bartz EK, Didehbani N, Keebler MW, Gardner CM, Strain JF, DeFina LF, Lu H (2015) Neural mechanisms of brain plasticity with complex cognitive training in healthy seniors. Cereb Cortex 25:396\u2013405","journal-title":"Cereb Cortex"},{"key":"12927_CR8","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.312","volume":"5","author":"TM Cruickshank","year":"2015","unstructured":"Cruickshank TM, Thompson JA, Dominguez DJ, Reyes AP, Bynevelt M, Georgiou-Karistianis N, Barker RA, Ziman MR (2015) The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington\u2019s disease: an exploratory study. Brain Behav 5:e00312","journal-title":"Brain Behav"},{"key":"12927_CR9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/01.wnl.0000238106.10423.00","volume":"67","author":"E Cubo","year":"2006","unstructured":"Cubo E, Shannon KM, Tracy D, Jaglin JA, Bernard BA, Wuu J, Leurgans SE (2006) Effect of donepezil on motor and cognitive function in Huntington disease. Neurology 67:1268\u20131271","journal-title":"Neurology"},{"key":"12927_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102312","volume":"97","author":"R Desai","year":"2024","unstructured":"Desai R, Leung WG, Fearn C, John A, Stott J, Spector A (2024) Effectiveness of Cognitive Stimulation Therapy (CST) for mild to moderate dementia: a systematic literature review and meta-analysis of randomised control trials using the original CST protocol. Ageing Res Rev 97:102312","journal-title":"Ageing Res Rev"},{"key":"12927_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JHD-239001","volume":"12","author":"C Estevez-Fraga","year":"2023","unstructured":"Estevez-Fraga C, Tabrizi SJ, Wild EJ (2023) Huntington\u2019s disease clinical trials corner: August 2023. J Huntingtons Dis 12:169\u2013185","journal-title":"J Huntingtons Dis"},{"key":"12927_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11920-009-0085-y","volume":"12","author":"N Gates","year":"2010","unstructured":"Gates N, Valenzuela M (2010) Cognitive exercise and its role in cognitive function in older adults. Curr Psychiatry Rep 12:20\u201327","journal-title":"Curr Psychiatry Rep"},{"key":"12927_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/rej.2015.1791","volume":"19","author":"C Giuli","year":"2016","unstructured":"Giuli C, Papa R, Lattanzio F, Postacchini D (2016) The effects of cognitive training for elderly: results from my mind project. Rejuvenation Res 19:485\u2013494","journal-title":"Rejuvenation Res"},{"key":"12927_CR14","first-page":"136","volume":"11","author":"HS Group","year":"1996","unstructured":"Group HS (1996) Unified Huntington\u2019s disease rating scale: reliability and consistency. Huntington Study Group Mov Disord 11:136\u2013142","journal-title":"Huntington Study Group Mov Disord"},{"key":"12927_CR15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1176\/appi.ajp.2016.16030360","volume":"174","author":"NT Hill","year":"2017","unstructured":"Hill NT, Mowszowski L, Naismith SL, Chadwick VL, Valenzuela M, Lampit A (2017) Computerized cognitive training in older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis. Am J Psychiatry 174:329\u2013340","journal-title":"Am J Psychiatry"},{"key":"12927_CR16","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1007\/s00415-023-11804-0","volume":"270","author":"A Horta-Barba","year":"2023","unstructured":"Horta-Barba A, Martinez-Horta S, Perez-Perez J, Puig-Davi A, de Lucia N, de Michele G, Salvatore E, Kehrer S, Priller J, Migliore S, Squitieri F, Castaldo A, Mariotti C, Mananes V, Lopez-Sendon JL, Rodriguez N, Martinez-Descals A, Julio F, Januario C, Delussi M, de Tommaso M, Noguera S, Ruiz-Idiago J, Sitek EJ, Wallner R, Nuzzi A, Pagonabarraga J, Kulisevsky J, Cognitive Phenotype Working Group of the European Huntington\u2019s Disease N (2023) Measuring cognitive impairment and monitoring cognitive decline in Huntington\u2019s disease: a comparison of assessment instruments. J Neurol 270:5408\u20135417","journal-title":"J Neurol"},{"key":"12927_CR17","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/mds.29972","volume":"39","author":"K Huynh","year":"2024","unstructured":"Huynh K, Georgiou-Karistianis N, Lampit A, Siddiqui MN, Stout JC, Jamadar SD (2024) Computerized cognitive training increases gray matter volumes in Huntington\u2019s disease: a pilot study. Mov Disord 39:2119\u20132121","journal-title":"Mov Disord"},{"key":"12927_CR18","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s00415-022-11516-x","volume":"270","author":"K Huynh","year":"2023","unstructured":"Huynh K, Nategh L, Jamadar S, Stout J, Georgiou-Karistianis N, Lampit A (2023) Cognition-oriented treatments and physical exercise on cognitive function in Huntington\u2019s disease: a systematic review. J Neurol 270:1857\u20131879","journal-title":"J Neurol"},{"key":"12927_CR19","volume":"2015","author":"Y Li","year":"2015","unstructured":"Li Y, Hai S, Zhou Y, Dong BR (2015) Cholinesterase inhibitors for rarer dementias associated with neurological conditions. Cochrane Database Syst Rev 2015:CD009444","journal-title":"Cochrane Database Syst Rev"},{"key":"12927_CR20","first-page":"1287822","volume":"14","author":"SL Ma","year":"2023","unstructured":"Ma SL, Tang KT, Lau NCT, Chiu CLH, Lin C, Lam LCW, Lee ATC (2023) Effect of computerized cognitive training on mood, cognition, and serum brain-derived neurotrophic factor level in late-life depression - a pilot randomized controlled trial. Front Psychiatry 14:1287822","journal-title":"Front Psychiatry"},{"key":"12927_CR21","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00415-020-09730-6","volume":"267","author":"S Martinez-Horta","year":"2020","unstructured":"Martinez-Horta S, Horta-Barba A, Perez-Perez J, Sampedro F, de Lucia N, De Michele G, Kehrer S, Priller J, Migliore S, Squitieri F, Castaldo A, Mariotti C, Mananes V, Lopez-Sendon JL, Rodriguez N, Martinez-Descals A, Garcia-Ruiz P, Julio F, Januario C, Delussi M, de Tommaso M, Noguera S, Ruiz-Idiago J, Sitek EJ, Nuzzi A, Pagonabarraga J, Kulisevsky J, Cognitive Phenotype Working Group of the European Huntington\u2019s Disease N (2020) Utility of the Parkinson\u2019s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington\u2019s disease. J Neurol 267:1527\u20131535","journal-title":"J Neurol"},{"key":"12927_CR22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","volume":"25","author":"S Martinez-Horta","year":"2016","unstructured":"Martinez-Horta S, Perez-Perez J, van Duijn E, Fernandez-Bobadilla R, Carceller M, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Ruiz-Idiago J, Sampedro F, Landwehrmeyer GB, RiotEHsDN S, Kulisevsky J (2016) Neuropsychiatric symptoms are very common in premanifest and early stage Huntington\u2019s Disease. Parkinsonism Relat Disord 25:58\u201364","journal-title":"Parkinsonism Relat Disord"},{"key":"12927_CR23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102415","volume":"28","author":"S Martinez-Horta","year":"2020","unstructured":"Martinez-Horta S, Sampedro F, Horta-Barba A, Perez-Perez J, Pagonabarraga J, Gomez-Anson B, Kulisevsky J (2020) Structural brain correlates of dementia in Huntington\u2019s disease. Neuroimage Clin 28:102415","journal-title":"Neuroimage Clin"},{"key":"12927_CR24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3233\/JHD-150164","volume":"4","author":"G McNally","year":"2015","unstructured":"McNally G, Rickards H, Horton M, Craufurd D (2015) Exploring the validity of the short version of the problem behaviours assessment (PBA-s) for Huntington\u2019s disease: a rasch analysis. J Huntingtons Dis 4:347\u2013369","journal-title":"J Huntingtons Dis"},{"key":"12927_CR25","volume":"12","author":"MJ Molnar","year":"2021","unstructured":"Molnar MJ, Molnar V, Fedor M, Csehi R, Acsai K, Borsos B, Grosz Z (2021) Improving mood and cognitive symptoms in Huntington\u2019s disease with cariprazine treatment. Front Psychiatry 12:825532","journal-title":"Front Psychiatry"},{"key":"12927_CR26","volume":"2","author":"V Orgeta","year":"2020","unstructured":"Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I (2020) Cognitive training interventions for dementia and mild cognitive impairment in Parkinson\u2019s disease. Cochrane Database Syst Rev 2:CD011961","journal-title":"Cochrane Database Syst Rev"},{"key":"12927_CR27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/mds.22007","volume":"23","author":"J Pagonabarraga","year":"2008","unstructured":"Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Gironell A (2008) Parkinson\u2019s disease-cognitive rating scale: a new cognitive scale specific for Parkinson\u2019s disease. Mov Disord 23:998\u20131005","journal-title":"Mov Disord"},{"key":"12927_CR28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","volume":"6","author":"JS Paulsen","year":"2014","unstructured":"Paulsen JS, Long JD, Johnson HJ, Aylward EH, Ross CA, Williams JK, Nance MA, Erwin CJ, Westervelt HJ, Harrington DL, Bockholt HJ, Zhang Y, McCusker EA, Chiu EM, Panegyres PK, Investigators P-H, Coordinators of the Huntington Study G (2014) Clinical and biomarker changes in premanifest huntington disease show trial feasibility: a decade of the PREDICT-HD study. Front Aging Neurosci 6:78","journal-title":"Front Aging Neurosci"},{"key":"12927_CR29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/mds.22953","volume":"25","author":"GM Peavy","year":"2010","unstructured":"Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J (2010) Cognitive and functional decline in Huntington\u2019s disease: dementia criteria revisited. Mov Disord 25:1163\u20131169","journal-title":"Mov Disord"},{"key":"12927_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10:204\u2013216","journal-title":"Nat Rev Neurol"},{"key":"12927_CR31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398","journal-title":"Lancet Neurol"},{"key":"12927_CR32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/PSY.0000000000001019","volume":"84","author":"F Sampedro","year":"2022","unstructured":"Sampedro F, Aracil-Bolanos I, Carmona IFC, Soler J, Schmidt C, Elices M, Pomarol-Clotet E, Salvador R, Vega D, Pascual JC (2022) A functional connectivity study to investigate the role of the right anterior insula in modulating emotional dysfunction in borderline personality disorder. Psychosom Med 84:64\u201373","journal-title":"Psychosom Med"},{"key":"12927_CR33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fneur.2018.00394","volume":"9","author":"F Sampedro","year":"2018","unstructured":"Sampedro F, Marin-Lahoz J, Martinez-Horta S, Pagonabarraga J, Kulisevsky J (2018) Early gray matter volume loss in MAPT H1H1 de Novo PD patients: a possible association with cognitive decline. Front Neurol 9:394","journal-title":"Front Neurol"},{"key":"12927_CR34","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","volume":"89","author":"SA Schobel","year":"2017","unstructured":"Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ, Track-Hd CC-H, Investigators CHSG (2017) Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. Neurology 89:2495\u20132502","journal-title":"Neurology"},{"key":"12927_CR35","first-page":"239","volume":"26","author":"S Sesok","year":"2014","unstructured":"Sesok S, Bolle N, Kobal J, Bucik V, Vodusek DB (2014) Cognitive function in early clinical phase huntington disease after rivastigmine treatment. Psychiatr Danub 26:239\u2013248","journal-title":"Psychiatr Danub"},{"key":"12927_CR36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","volume":"4","author":"SE Starkstein","year":"1992","unstructured":"Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 4:134\u2013139","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"12927_CR37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ, Munoz-Sanjuan I, Sampaio C, Rosser AE, Leavitt BR (2022) Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol 21:645\u2013658","journal-title":"Lancet Neurol"},{"key":"12927_CR38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC, investigators T-H, (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8:791\u2013801","journal-title":"Lancet Neurol"},{"key":"12927_CR39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, investigators T-H (2012) Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11:42\u201353","journal-title":"Lancet Neurol"},{"key":"12927_CR40","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/ene.12053","volume":"20","author":"JA Thompson","year":"2013","unstructured":"Thompson JA, Cruickshank TM, Penailillo LE, Lee JW, Newton RU, Barker RA, Ziman MR (2013) The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington\u2019s disease: a pilot study. Eur J Neurol 20:1325\u20131329","journal-title":"Eur J Neurol"},{"key":"12927_CR41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/hbm.20531","volume":"30","author":"LQ Uddin","year":"2009","unstructured":"Uddin LQ, Kelly AM, Biswal BB, Castellanos FX, Milham MP (2009) Functional connectivity of default mode network components: correlation, anticorrelation, and causality. Hum Brain Mapp 30:625\u2013637","journal-title":"Hum Brain Mapp"},{"key":"12927_CR42","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E van Duijn","year":"2014","unstructured":"van Duijn E, Craufurd D, Hubers AA, Giltay EJ, Bonelli R, Rickards H, Anderson KE, van Walsem MR, van der Mast RC, Orth M, Landwehrmeyer GB, European Huntington\u2019s Disease Network Behavioural Phenotype Working G (2014) Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 85:1411\u20131418","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12927_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/JHD-180294","volume":"7","author":"MR van Walsem","year":"2018","unstructured":"van Walsem MR, Piira A, Mikalsen G, Fossmo HL, Howe EI, Knutsen SF, Frich JC (2018) Cognitive performance after a one-year multidisciplinary intensive rehabilitation program for Huntington\u2019s disease: an observational study. J Huntingtons Dis 7:379\u2013389","journal-title":"J Huntingtons Dis"},{"key":"12927_CR44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"12927_CR45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JHD-210475","volume":"11","author":"JH Warner","year":"2022","unstructured":"Warner JH, Long JD, Mills JA, Langbehn DR, Ware J, Mohan A, Sampaio C (2022) Standardizing the CAP score in Huntington\u2019s disease by predicting age-at-onset. J Huntingtons Dis 11:153\u2013171","journal-title":"J Huntingtons Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-12927-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-12927-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-12927-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:42:37Z","timestamp":1742218957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-12927-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["12927"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-12927-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study has been approved by the Hospital de la Santa Creu i Sant Pau ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A.P.-D. is supported by a grant from the Government of Andorra (ATC027-AND\/2021). S.M.-H. has received honoraria for lecturing from Teva, Zambon, UCB, Bial, and Roche, and reports grants from Huntington\u2019s disease Society of America (Human Biology Project), and from Fondo de Investigaciones Sanitarias (FIS) from Instituto de Salud Carlos III (ISCIII). J.P.-P. reports a grant from Fondo de Investigaciones Sanitarias (FIS) from Instituto de Salud Carlos III (ISCIII). JP has received honoraria for advisory boards or lecturing from: Teva, Zambon, UCB, Bial, Sanofi, and Roche. J.K. has received honoraria for advisory boards or lecturing from: Teva, Zambon, UCB, Bial, General Electric, Sanofi, and Roche, and reports grants from Fundaci\u00f3 la Marato de TV3, Fondo de Investigaciones Sanitarias (FIS) from Instituto de Salud Carlos III (ISCIII), and Fondo Europeo de Desarrollo Regional (FEDER). The authors declare that there is no conflict of interest regarding the publication of this article. The research group also receives funds from CERCA (CEntres de Recerca de CAtalunya) and CIBERNED (Centro de Investigaci\u00f3n Biom\u00e9dica en Red de enfermedades NEuroDegenerativas).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"202"}}